Antisense Oligonucleotides: A Unique Treatment Approach

被引:10
|
作者
Krishnan, Abhinaya V. [1 ]
Mishra, Devendra [1 ]
机构
[1] Univ Delhi, Maulana Azad Med Coll, Dept Pediat, Delhi 110002, India
关键词
Duchenne muscular dystrophy; Eteplirsen; Nusinersen; Spinal muscular atrophy; Treatment; SHAM CONTROL; NUSINERSEN; THERAPIES; SAFETY; TRIAL;
D O I
10.1007/s13312-020-1736-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Synthetic Antisense oligonucleotides (ASOs) are novel and efficient laboratory tools to regulate the expression of specific genes, and have only recently come into clinical use. These are synthetic single-stranded DNA analogs, whose sequence is complementary to a target nucleotide and alter protein synthesis by several mechanisms. We herein provide a primer on the topic for pediatricians, as this group of drugs is likely to see many more drugs for previously incurable diseases.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [11] Antisense Oligonucleotides for the Study and Treatment of ALS
    Boros, Benjamin D.
    Schoch, Kathleen M.
    Kreple, Collin J.
    Miller, Timothy M.
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1145 - 1158
  • [12] Treatment of Usher syndrome with antisense oligonucleotides
    Lentz, Jennifer
    Flaat, Mette
    Jodelka, Francine
    Hinrich, Anthony
    Zhou, Yongdong
    McCaffery, Kate
    Duelli, Dominik
    Bazan, Nicolas
    Rigo, Frank
    Hastings, Michelle
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [13] Antisense Oligonucleotides for the Treatment of Hypertriglyceridemia and Hyperlipoproteinemia(a)
    Hanssen R.
    Gouni-Berthold I.
    Current Pharmacology Reports, 2017, 3 (6) : 458 - 468
  • [14] Antisense Oligonucleotides for the Study and Treatment of ALS
    Benjamin D. Boros
    Kathleen M. Schoch
    Collin J. Kreple
    Timothy M. Miller
    Neurotherapeutics, 2022, 19 : 1145 - 1158
  • [15] Antisense oligonucleotides as drugs for HIV treatment
    Galderisi, U
    Cipollaro, M
    Cascino, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (10) : 1605 - 1611
  • [16] Antisense oligonucleotides: a novel therapeutic approach.
    Guinot, P
    Temsamani, J
    PATHOLOGIE BIOLOGIE, 1998, 46 (05): : 347 - 354
  • [17] Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
    Hastings, Michelle L.
    Jones, Timothy A.
    NEUROTHERAPEUTICS, 2019, 16 (02) : 348 - 359
  • [18] A review of antisense oligonucleotides in the treatment of human disease
    Rubenstein, M
    Tsui, R
    Guinan, P
    DRUGS OF THE FUTURE, 2004, 29 (09) : 893 - 909
  • [19] Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
    Michelle L. Hastings
    Timothy A. Jones
    Neurotherapeutics, 2019, 16 : 348 - 359
  • [20] The future of antisense oligonucleotides in the treatment of respiratory diseases
    Ulanova, M
    Schreiber, AD
    Befus, AD
    BIODRUGS, 2006, 20 (01) : 1 - 11